Literature DB >> 9699725

Rac1 mediates dendrite formation in response to melanocyte stimulating hormone and ultraviolet light in a murine melanoma model.

G A Scott1, L Cassidy.   

Abstract

Melanocytes are pigment producing cells that reside in the basal layer of the epidermis, and form multiple long dendritic processes that transport melanosomes from the melanocyte cell body to the dendritic tips, and then to keratinocytes. Dendrite formation requires actin polymerization in the newly forming dendrite, and dendrite formation in melanocytes is stimulated by hormones and ultraviolet light. The rho-subfamily of monomeric guanosine triphosphate-binding proteins is implicated in remodeling the cellular actin cytoskeleton, resulting in the formation of filopodia, lamellipodia, and stress fibers, as well as in oncogenesis and activation of the Jun/p38 mitogen activated kinase cascade. In this paper we show that rac1 induces the formation of dendrite-like structures when activated mutants are transiently expressed in B16F1 murine melanoma cells and in four human melanoma cell lines. Activated mutants of cdc42 and rhoA induced the formation of filopodia and stress fibers, respectively, in B16F1 cells, but not dendrites. A dominant negative inhibitor of rac1 abrogated the ability of alpha-melanocyte stimulating hormone, a peptide hormone known to stimulate melanocyte dendrite formation, and ultraviolet light, to induce dendrite formation in B16F1 cells, and alpha-melanocyte stimulating hormone and ultraviolet light stimulated the localization of rac1 to dendrite cell membranes. These results suggest that rac1 is an important signaling intermediate in dendrite formation in B16F1 cells, and that rac1 mediates the well-known ability of alpha-melanocyte stimulating hormone and ultraviolet light to induce dendrite formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699725     DOI: 10.1046/j.1523-1747.1998.00276.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  18 in total

1.  The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression.

Authors:  M D Galibert; S Carreira; C R Goding
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

2.  A novel agent, methylophiopogonanone B, promotes Rho activation and tubulin depolymerization.

Authors:  Yuko Ito; Akiko Kanamaru; Akihiro Tada
Journal:  Mol Cell Biochem       Date:  2006-10-07       Impact factor: 3.396

3.  MicroRNA 340 is involved in UVB-induced dendrite formation through the regulation of RhoA expression in melanocytes.

Authors:  Qiang Jian; Qing An; Dongning Zhu; Kun Hui; Ying Liu; Sumin Chi; Chengxin Li
Journal:  Mol Cell Biol       Date:  2014-06-30       Impact factor: 4.272

Review 4.  Leveraging melanocortin pathways to treat glomerular diseases.

Authors:  Rujun Gong
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

5.  Melanocortin 1 receptor regulates melanoma cell migration by controlling syndecan-2 expression.

Authors:  Heesung Chung; Jung-hyun Lee; Dayun Jeong; Inn-Oc Han; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

6.  Prostaglandin E2 regulates melanocyte dendrite formation through activation of PKCzeta.

Authors:  Glynis Scott; Alex Fricke; Anne Fender; Lindy McClelland; Stacey Jacobs
Journal:  Exp Cell Res       Date:  2007-08-16       Impact factor: 3.905

7.  The Long Noncoding RNA SPRIGHTLY Regulates Cell Proliferation in Primary Human Melanocytes.

Authors:  Wei Zhao; Joseph Mazar; Bongyong Lee; Junko Sawada; Jian-Liang Li; John Shelley; Subramaniam Govindarajan; Dwight Towler; John S Mattick; Masanobu Komatsu; Marcel E Dinger; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2016-01-29       Impact factor: 8.551

8.  Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism.

Authors:  Ang Li; Yafeng Ma; Meng Jin; Susan Mason; Richard L Mort; Karen Blyth; Lionel Larue; Owen J Sansom; Laura M Machesky
Journal:  J Invest Dermatol       Date:  2012-06-21       Impact factor: 8.551

9.  Knowledge building insights on biomarkers of arsenic toxicity to keratinocytes and melanocytes.

Authors:  Raphael D Isokpehi; Udensi K Udensi; Matthew N Anyanwu; Andreas N Mbah; Matilda O Johnson; Kafui Edusei; Michael A Bauer; Roger A Hall; Omotayo R Awofolu
Journal:  Biomark Insights       Date:  2012-10-15

10.  The role of the hippo pathway in melanocytes and melanoma.

Authors:  Ji Eun Kim; Graeme J Finlay; Bruce C Baguley
Journal:  Front Oncol       Date:  2013-05-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.